Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-02

Study Completion Date

2030-10-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Financial Toxicity in Cancer Patients

NCT04592250

Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm

ACTIVE_NOT_RECRUITING

Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic

NCT03043378

Malignant Neoplasms of Independent (Primary) Multiple Sites

COMPLETED

Interventions to Decrease Financial Toxicity

NCT05939440

Cancer, Breast Cancer Colorectal Cancer, Ovarian +3 more

COMPLETED NA

Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings

NCT04931251

Neoplasms Carcinoma

COMPLETED NA

Patient-Centered Intervention to Reduce Cancer Patients' Financial Toxicity

NCT04314284

Gynecologic Cancer Colorectal Cancer Lung Cancer

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Measure the prevalence of financial toxicity and the severity of it in orthopaedic oncology patients undergoing surgical intervention using an objective, validated instrument. Secondary objectives include identifying socioeconomic and demographic risk factors for financial toxicity and evaluating clinicopathologic characteristics that may worsen financial stress in this population.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bone Sarcomas Financial Toxicity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

data collection

data collection from electronic health records

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants who are seen preoperatively at our institution before surgery for primary malignant bone tumor or primary malignant soft tissue tumor will be identified.
* Adult orthopedic oncology patients. Stratified by diagnosis of primary malignant bone tumor and primary malignant soft tissue tumor.